{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:01:57Z","timestamp":1781118117744,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2016ZC0116"],"award-info":[{"award-number":["2016ZC0116"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Clinical Practice Guidelines (CPGs) play an important role in clinical practice, and they require appropriate evaluation, especially in application. This study explores the application evaluation method of CPGs for Traditional Chinese Medicines (TCM). It uses the Analytic Hierarchy Process (AHP) and clinical cases to evaluate the consistency between CPGs of TCM and clinical practice.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To evaluate the consistency between CPGs of TCM and clinical cases, a 3-level AHP construction was built. Weightings were calculated by collecting questionnaires according to AHP theory. To test the evaluation system, a retrospective study was performed. The study evaluated the China Association of Chinese Medicine\u2019s Guidelines for Diagnosis and Treatment of Common Internal Diseases in Chinese Medicine Diseases of Modern Medicine (CPGs of DTCID) (ZYYXH\/T50\u2013135-2008). A total of 150 cases were involved. The evaluation system was used to assess the consistency between CPGs of DTCID and clinical cases of angina pectoris.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results showed that the overall consistency between CPGs of DTCID and the 150 cases was 42.32\u2009\u00b1\u20096.94%, ranging from 35.21 to 63.37%. The overall consistency was not affected by age, gender, type of angina pectoris, condition of percutaneous coronary intervention (PCI), or angina classification as determined by the Canadian Cardiovascular Society. The consistencies of each index were as follows: Diagnosis of TCM, 100%; Diagnosis of Western medicine, 100%; Syndrome classification, 38.25\u2009\u00b1\u20094.40%; Syndrome key point, 34.17\u2009\u00b1\u20098.15%; TCM Decoction, 31.08\u2009\u00b1\u200923.64%; TCM particular treatment, 7.92\u2009\u00b1\u200919.13%; and Recuperation and prevention, 0. The most frequent syndromes were <jats:italic>qi<\/jats:italic>-deficiency, phlegm and blood stasis (<jats:italic>n<\/jats:italic>\u2009=\u2009124) (82.7%). The overall consistency of <jats:italic>qi<\/jats:italic>-deficiency, turbid phlegm and blood stasis was lower than the overall consistency of the group without that syndrome. The difference was statistically significant (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). 42 cases (28%) applied the TCM decoction recommended by CPGs of DTCID. Of these, <jats:italic>Gualouxiebaibanxia<\/jats:italic> decoction was applied in 34 cases. <jats:italic>Wendan<\/jats:italic> decoction, the most frequently used, was applied in 64 cases (42.7%).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study indicates that the AHP system can perform quantitative evaluation of consistency between TCM CPG and clinical practice. It also found the factors affecting the application of TCM CPGs and might indicate the need for revisions of CPGs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-019-2683-5","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T04:29:57Z","timestamp":1571804997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Application evaluation of clinical practice guidelines for traditional Chinese medicine: a clinical analysis based on the analytic hierarchy process"],"prefix":"10.1186","volume":"19","author":[{"given":"Huayang","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"2683_CR1","volume-title":"Guidelines for clinical practice:from development to use","author":"MJ Field","year":"1992","unstructured":"Field MJ, Lohr KN. Guidelines for clinical practice:from development to use. \\: \\National Academy Press1992:27."},{"issue":"4","key":"2683_CR2","first-page":"334","volume":"5","author":"B Wang","year":"2013","unstructured":"Wang B, Zhan SY. The method and experiment for development of evidence-based clinical practice guidelines. Chin J Evid Based Cardiovasc Med. 2013;5(4):334\u20136.","journal-title":"Chin J Evid Based Cardiovasc Med"},{"key":"2683_CR3","first-page":"230","volume":"3","author":"ZH Zheng","year":"2011","unstructured":"Zheng ZH, Cui SQ, Huang F, et al. Analyzing and evaluating the influence and timeliness of developing clinical practice guidelines. Chin Health Serv Manage. 2011;3:230\u20132.","journal-title":"Chin Health Serv Manage"},{"key":"2683_CR4","doi-asserted-by":"crossref","unstructured":"Brouwers MC, et al. AGREE Next Steps Consortium. AGREEII:advancing guideline development, reporting, and evaluation in health care. Can Med Assoc J. 2010;182(19):E839\u201342.","DOI":"10.1503\/cmaj.090449"},{"issue":"9","key":"2683_CR5","first-page":"11","volume":"9","author":"DJ Liu","year":"2012","unstructured":"Liu DJ, Chen JG, Li Y. The development of a chinizational evaluation instrument for clinical practice guidelines. Chin Med Equip. 2012;9(9):11\u20134.","journal-title":"Chin Med Equip"},{"key":"2683_CR6","first-page":"33","volume":"1","author":"M Liu","year":"2006","unstructured":"Liu M. Importance, development and evaluation of clinical practice guidelines. Chin J Stroke. 2006;1:33\u20136.","journal-title":"Chin J Stroke"},{"issue":"4","key":"2683_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3736\/jcim20090401","volume":"7","author":"KY Chen","year":"2009","unstructured":"Chen KY, Jiang YR. Situation and problems of clinical practice guidelines development of traditional Chinese medicine and integrative medicine. J Chin Integr Med. 2009;7(4):301\u20135.","journal-title":"J Chin Integr Med"},{"key":"2683_CR8","volume-title":"Analytic hierarchy process and application cases","author":"BJ Zhang","year":"2014","unstructured":"Zhang BJ. Analytic hierarchy process and application cases. 1st ed. Beijing: Publishing house of electronics industry; 2014.","edition":"1"},{"key":"2683_CR9","volume-title":"Guidelines for Diagnosis and Treatment of Common Internal Diseases in Chinese Medicine Diseases of Modern Medicine","author":"China Association of Chinese Medicine","year":"2008","unstructured":"China Association of Chinese Medicine. Guidelines for Diagnosis and Treatment of Common Internal Diseases in Chinese Medicine Diseases of Modern Medicine. 1st ed. Beijing: China Press of Traditional Chinese Medicine; 2008.","edition":"1"},{"key":"2683_CR10","volume-title":"Medicine statistics 3rd ed","author":"ZQ Sun","year":"2002","unstructured":"Sun ZQ. Medicine statistics 3rd ed. Beijing: People's Health Publishing House; 2002."},{"issue":"3","key":"2683_CR11","first-page":"257","volume":"10","author":"YH Jin","year":"2018","unstructured":"Jin YH, Han F, Wang Q, et al. Methodology for clinical practice guidelines --identifying and forming the scope, topic and clinical. Chin J Evid Based Cardiovasc Med. 2018;10(3):257\u201361.","journal-title":"Chin J Evid Based Cardiovasc Med"},{"key":"2683_CR12","volume-title":"Heath Technology assessment","author":"J Chen","year":"2013","unstructured":"Chen J, Yu DZ. Heath Technology assessment. 1st ed. Beijing: People's Health Publishing House; 2013.","edition":"1"},{"issue":"4","key":"2683_CR13","first-page":"596","volume":"13","author":"Y Yuwen","year":"2011","unstructured":"Yuwen Y, Han XJ, Zhang H, et al. Study on quality assessment of TCM clinical practice guidelines based on AGREE instrument. World Sci Technol Modernization Tradit Chin Med Materia Med. 2011;13(4):596\u2013600.","journal-title":"World Sci Technol Modernization Tradit Chin Med Materia Med"},{"issue":"1","key":"2683_CR14","first-page":"11","volume":"36","author":"YR Jiang","year":"2016","unstructured":"Jiang YR, Chen KJ. Development and quality evaluation of evidence-based clinical practice guidelines of Chinese medicine. Chin J Integr Tradit West Med. 2016;36(1):11\u20135.","journal-title":"Chin J Integr Tradit West Med"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-019-2683-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:10:27Z","timestamp":1603235427000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-019-2683-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2683"],"URL":"https:\/\/doi.org\/10.1186\/s12906-019-2683-5","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"25 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For this study was performed as a retrospective clinical study and the information of clinical cases was collected form the cases database in the computer, we applied for exemption from ethical review(Application Number B2013\u2013175) before the study began in 2013.In compliance to the Good Clinical Practice for Clinical Trial of New Drugs, Guidelines for Ethics Review of Drugs Clinical trial (approved by China Food and Drug Administration), Ethics Review for Biomedical Research Involving Human Subjects, Management of Clinical Research on Stem Cells (for Trial Implementation) (issued by Ministry of Public Health of China), Standards for Ethics Review Platform Construction of Chinese Medical Research (issued by State Administration of Traditional Chinese Medicine), Declaration of Helsinki, International Ethical Guideline for Biomedical Research involving Human Subjects, the Ethics Committee of Guangdong Provincial Hospital of Chinese Medicine agrees the exemption from Review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"277"}}